References
Kozaki M, Sakuma S, Kudaka W, Kinjyo Y, Taira Y, Arakaki Y, Shimoji Y, Nakasone T, Nakamoto T, Wakayama A, Ooyama T (2017) Therapy-free interval has prognostic value in patients with recurrent cervical cancer treated with chemotherapy following definitive concurrent chemoradiotherapy. Arch Gynecol Obstet 296(5):997–1003
Kleinbaum DG, Klein M (2010) Survival analysis. Springer, New York
Hosmer DW Jr, Lemeshow S, Sturdivant RX (2013) Applied logistic regression. Wiley, New York
Steyerberg EW (2008) Clinical prediction models: a practical approach to development, validation, and updating. Springer Science & Business Media, New York
Funding
There is no funding for this article.
Author information
Authors and Affiliations
Contributions
Conception of study design: AAA and SS. Drafting manuscript: AAA and SS. Critically revised manuscript: AAA and SS. All authors approved the final version for submission.
Corresponding author
Ethics declarations
Conflict of interest
We have no conflict of interest as to this article.
Ethical approval
None.
Rights and permissions
About this article
Cite this article
Ashrafi-Asgarabad, A., Safiri, S. Therapy-free interval has prognostic value in patients with recurrent cervical cancer treated with chemotherapy following definitive concurrent chemoradiotherapy: methodological issues. Arch Gynecol Obstet 297, 805–806 (2018). https://doi.org/10.1007/s00404-017-4629-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-017-4629-9